US Patent 11224575 Anticancer compositions
Patent 11224575 was granted and assigned to Aragon Pharmaceuticals on January, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 19, 2019
0
Date of Patent
January 18, 2022
0
Patent Applicant
Patent Application Number
16357821
0
Patent Citations Received
Patent Inventor Names
Geert Verreck
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11224575 Anticancer compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
